Atipamezole

Generic Name: Atipamezole

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₄H_₁₆N_₂

CAS Number: 104054-27-5

Unique Ingredient Identifier: 03N9U5JAF6

Background: Atipamezole is a synthetic α2 adrenoceptor antagonistused to reverse the sedative and analgesic effects of dexmedetomidine and medetomidine in dogs. It has also been undergone research as a potential anti-Parkinsonian drug for humans.

Indication: For the reversal of the sedative and analgesic effects of dexmedetomidine and medetomidine in dogs.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Competition With Striatal [11C]ORM-13070 Binding by Atipamezole and Endogenous Noradrenaline

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Ketamine
Drug: Insulin
Other: Cold pressor test
Drug: Placebo
Drug: Atipamezole
Drug: Atomoxetine

First Posted Date: 2011-09-16

Last Posted Date: 2013-02-18

Lead Sponsor: University of Turku

Target Recruit Count: 10

Registration Number: NCT01435213

Locations: 🇫🇮
University of Turku, Clinical Research Services Turku CRST, Turku, Finland
🇫🇮
University of Turku, Turku PET Centre, Turku, Finland

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy